|

PEG-rhG-CSF Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • The Affiliated People's Hospital of Ningbo University2
  • Chinese Academy of Medical Sciences1

Indications

  • Cancer3
  • Hematopoietic Stem Cell Mobilization1
  • Non-Hodgkin's Lymphoma1
  • Lymphoma1
  • Multiple Myeloma1

Other3 trials

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Phase 3
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
N/A
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.